Steffes Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451K Buy
18,733
+301
+2% +$7.87K 0.19% 22
2026
Q1
$518K Buy
18,432
+295
+2% +$7.85K 0.27% 20
2025
Q4
$452K Buy
+18,137
New +$457K 0.24% 19

Other funds holding PFE

Steffes Financial's PFE Position: Q2 2026 in Review

Steffes Financial increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $7.87K and bringing the position to 18,733 shares worth $451K. The position accounts for 0.19% of the portfolio, ranked #22.

Steffes Financial first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $518K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Steffes Financial held 18,733 shares of Pfizer worth $451K as of Q2 2026.
  • Steffes Financial bought 301 Pfizer shares in Q2 2026, an estimated $7.87K.
  • Pfizer made up 0.19% of Steffes Financial's portfolio in Q2 2026, its #22 holding.
  • Steffes Financial first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Steffes Financial's Pfizer position peaked at $518K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Steffes Financial's 13F filing for Q2 2026, filed 14 Aug 2026.